RIL
VRTX icon

Rothschild Investment LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Rothschild Investment LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Buy
4,038
+3,601
+824% +$1.6M 0.08% 249
2026
Q1 		$195K Buy
437
+50
+13% +$23.3K 0.01% 678
2025
Q4 		$175K Buy
387
+41
+12% +$17.7K 0.01% 664
2025
Q3 		$136K Sell
346
-67
-16% -$28K 0.01% 721
2025
Q2 		$184K Buy
413
+4
+1% +$1.84K 0.01% 528
2025
Q1 		$198K Sell
409
-248
-38% -$116K 0.01% 502
2024
Q4 		$265K Sell
657
-5
-0.8% -$2.32K 0.02% 443
2024
Q3 		$308K Sell
662
-24
-3% -$11.5K 0.02% 424
2024
Q2 		$322K Buy
686
+420
+158% +$182K 0.02% 407
2024
Q1 		$111K Buy
266
+26
+11% +$11K 0.01% 578
2023
Q4 		$97.7K Buy
+240
New +$88.7K 0.01% 536

Other funds holding VRTX

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Rothschild Investment LLC's VRTX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Vertex Pharmaceuticals (VRTX) stake by 824% in Q2 2026, buying an estimated $1.6M and bringing the position to 4,038 shares worth $2.01M. The position accounts for 0.08% of the portfolio, ranked #249.

Rothschild Investment LLC first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 945 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Rothschild Investment LLC held 4,038 shares of Vertex Pharmaceuticals worth $2.01M as of Q2 2026.
  • Rothschild Investment LLC bought 3,601 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.6M.
  • Vertex Pharmaceuticals made up 0.08% of Rothschild Investment LLC's portfolio in Q2 2026, its #249 holding.
  • Rothschild Investment LLC first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 945 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.